Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: CARYTRE who wrote (1159)	1/16/1998 1:08:00 AM
From: XaviarCane	Read Replies (1) \| Respond to of 1894

George, Are you still with us? I haven't seen you post in a while. Just curious. -X. Cane

To: CARYTRE who wrote (1159)	1/16/1998 8:51:00 AM
From: Frank Buck	Read Replies (1) \| Respond to of 1894

Cary, All your points are well taken, but #5 in particular is very important. 5) Retaining manfacturing sounds like a big plus too. Since there should be built in profit margin there, for 100% of the goods. More efficient capital utilization leads to higher return on equity. AccuMed should realize escalating margin capabilities with an increasingly higher number of units manufactured and sold; margin of scale. Was #6, corn(y) seeds you were sowing? I thought I was the only one that planted that particular kernel. Thanks for joining me. Must be a writing characteristic of us midwesterners.<G> Frank